Bayer, GE, Covidien MRI Agents Carry Higher Risk: FDA
A U.S. Food and Drug Administration staff review has found that certain gadolinium-based contrast agents used during MRI procedures may pose more of a risk of a fatal skin disease than...To view the full article, register now.
Already a subscriber? Click here to view full article